Commerce Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Commerce Bank's RPRX Position: Q2 2026 in Review
Commerce Bank increased its Royalty Pharma (RPRX) stake by 0.66% in Q2 2026, buying an estimated $2.39K and bringing the position to 7,015 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #1052.
Commerce Bank first reported a position in RPRX in Q2 2022 and has held it in 7 quarters since. 644 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Commerce Bank held 7,015 shares of Royalty Pharma worth $393K as of Q2 2026.
- Commerce Bank bought 46 Royalty Pharma shares in Q2 2026, an estimated $2.39K.
- Royalty Pharma made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #1052 holding.
- Commerce Bank first reported a position in Royalty Pharma in Q2 2022 and has held it in 7 quarters since.
- 644 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.